Menu
Back to User profile » Dr William Valentine
Papers published by Dr William Valentine:
Evaluating the Impact of Therapy on Quality of Life in Type 2 Diabetes: A Literature Review of Utilities Associated with Treatment-Related Attributes
Valentine W, Norrbacka K, Boye KS
Patient Related Outcome Measures 2022, 13:97-111
Published Date: 12 May 2022
Evaluation of the Long-Term Cost-Effectiveness of the Dexcom G6 Continuous Glucose Monitor versus Self-Monitoring of Blood Glucose in People with Type 1 Diabetes in Canada
Roze S, Isitt JJ, Smith-Palmer J, Lynch P
ClinicoEconomics and Outcomes Research 2021, 13:717-725
Published Date: 11 August 2021
Evaluation of the Cost-Effectiveness of Iron Formulations for the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease in the UK
Aksan A, Beales ILP, Baxter G, Ramirez de Arellano A, Gavata S, Valentine WJ, Hunt B
ClinicoEconomics and Outcomes Research 2021, 13:541-552
Published Date: 17 June 2021
Impact of Stigma on People Living with Chronic Hepatitis B
Smith-Palmer J, Cerri K, Sbarigia U, Chan EKH, Pollock RF, Valentine WJ, Bonroy K
Patient Related Outcome Measures 2020, 11:95-107
Published Date: 9 March 2020
Cost of achieving HbA1c and weight loss treatment targets with IDegLira vs insulin glargine U100 plus insulin aspart in the USA
Billings LK, Mocarski M, Basse A, Hunt B, Valentine WJ, Jodar E
ClinicoEconomics and Outcomes Research 2019, 11:271-282
Published Date: 21 March 2019
Cost-effectiveness of the COPD Patient Management European Trial home-based disease management program
Bourbeau J, Granados D, Roze S, Durand-Zaleski I, Casan P, Köhler D, Tognella S, Viejo JL, Dal Negro RW, Kessler R
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:645-657
Published Date: 14 March 2019
Evaluating the cost-effectiveness of insulin detemir versus neutral protamine Hagedorn insulin in patients with type 1 or type 2 diabetes in the UK using a short-term modeling approach
Pollock RF, Chubb B, Valentine WJ, Heller S
Diabetes, Metabolic Syndrome and Obesity 2018, 11:217-226
Published Date: 16 May 2018
Evaluating the cost-effectiveness of afatinib after platinum-based therapy for the treatment of squamous non-small-cell lung cancer in France
Pignata M, Chouaid C, Le Lay K, Luciani L, McConnachie C, Gordon J, Roze S
ClinicoEconomics and Outcomes Research 2017, 9:655-668
Published Date: 25 October 2017
Evaluating health-related quality of life in type 1 diabetes: a systematic literature review of utilities for adults with type 1 diabetes
Smith-Palmer J, Bae JP, Boye KS, Norrbacka K, Hunt B, Valentine WJ
ClinicoEconomics and Outcomes Research 2016, 8:559-571
Published Date: 7 October 2016
Evaluation of the cost per patient per injection of botulinum toxin A in upper limb spasticity: comparison of two preparations in 19 countries
Roze S, Kurth H, Hunt B, Valentine W, Marty R
Medical Devices: Evidence and Research 2012, 5:97-101
Published Date: 20 November 2012